It should be pointed out that the $350,000.00 BioCurex must raise prior to October 1, 2009, to avoid default, is needed in order to pay the expenses associated with the $3,000,000.00 Public Offering and fund working capital. None of the $350,000.00 that BioCurex must raise prior to October 1, 2009 is scheduled to be used to reduce the Smithline debt. kag